A pain-informed model identified risk factors for clinically significant nausea in patients undergoing metabolic bariatric surgery.
SEED Therapeutics, Inc. (“SEED”), a clinical-stage biotechnology company pioneering rationally designed molecular glue ...
Objectives To examine if early adoption into a family with favourable home environment conditions reduces long term ...
Background Native aortic valve endocarditis continues to present significant operative challenges, often complicated by heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results